Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers

Pancreas

Volumn 42, Issue 2, 2013, Pages 198-201

  Aggarwal, Gaurav ^a   Kamada, Pratima ^b   Chari, Suresh T ^a  

^a MAYO CLINIC   (United States)

^b University Medical Center Brackenridge   (United States)

Author keywords

diabetes mellitus; pancreatic cancer; screening

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CASE CONTROL STUDY; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PANCREAS CANCER; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DIABETES MELLITUS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MINNESOTA; PANCREATIC NEOPLASMS; PREVALENCE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84874114984     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182592c96     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
2. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053.
3. Altekruse SF, Kosary CL, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1976-2007, National Cancer Institute. Bethesda, MD, based on November 2009 SEER data submission, posted to the SEERWeb site, 2010. Available at: http://www.cancer.org/cancer/cancerbasics/cancer-prevalence. Accessed on June 1, 2011.
4. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: A consensus report. Diabetes Care. 2010;33(7):1674-1685.
5. Vigneri P, Frasca F, Sciacca L, et al. Diabetes and cancer. Endocr Relat Cancer. 2009;16:1103-1123.
6. Smith U, Gale EA. Does diabetes therapy influence the risk of cancer? Diabetologia. 2009;52(9):1699-1708.
7. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies. Br J Cancer. 2005;92:2076-2083.
8. Pannala R, Basu A, Petersen GM, et al. New-onset diabetes: A potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 2009;10(1):88-95.
9. Chari ST, Klee GG, Miller LJ, et al. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology. 2001;121:640-645.
10. Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008;134(4):981-987.
11. Chari ST, Leibson CL, de Andrade M, et al. Probability of pancreatic cancer following diabetes: A population-based study. Gastroenterology. 2005;129:504-511.
12. Permert J, Adrian TE, Jacobsson P, et al. Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg. 1993;165:61-66.
13. Engelgau MM. Diabetes diagnostic criteria and impaired glycemic states: Evolving evidence base. Clinical Diabetes. 2004;22:69-70.
14. Vella A, Camilleri M, Rizza RA. The gastrointestinal tract and glucose tolerance. Curr Opin Clin Nutr Metab Care. 2004;7:479-484.
15. Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in nonYinsulin-dependent diabetes mellitus. N Engl J Med. 1992;327:707-713.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(suppl 1):S55-S60.
17. Pelaez-Luna M, Takahashi N, Fletcher JG, et al. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: A retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol. 2007;102(10):2157-2163.
18. Permert J, Ihse I, Jorfeldt L, et al. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg. 1993;80:1047-1050.
19. Fogar P, Pasquali C, Basso D, et al. Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res. 1994;14:2827-2830.
20. Permert J, Larsson J, Fruin AB, et al. Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas. 1997;15:60-68.
21. Basso D, Plebani M, Fogar P, et al. Beta-cell function in pancreatic adenocarcinoma. Pancreas. 1994;9:332-335.
22. Isaksson B, Strommer L, Friess H, et al. Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients. Pancreas. 2003;26:173-177.